Overexpression of ENTPD3 in breast cancer cell lines inhibited EMT through regulating eATP [44], and abnormal regulation of EMT in endometrial epithelial cells was closely associated with impaired endometrial receptivity [4]. This evidence concerns the gene ENTPD3 and breast carcinoma.